Revenue
$72.3M
▲ 153.5% YoY
Net Income
-$6.1M
▲ 84.8% YoY
EPS
$-0.55
▲ 91.8% YoY
Cash
$58.5M
▲ 52.4% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. 10% Owner | Grant | May 26, 2026 | 471.7K | $26.50 | $12.50M | Form 4 ↗ |
Gaggar Anuj Chief Medical Officer | Grant | Mar 29, 2026 | 14.0K | $0.00 | $0 | Form 4 ↗ |
White Nicole S Chief Manufacturing Officer | Grant | Mar 29, 2026 | 14.0K | $0.00 | $0 | Form 4 ↗ |
Bjorkquist Jeanette M PFO and PAO | Grant | Mar 29, 2026 | 3.5K | $0.00 | $0 | Form 4 ↗ |
Delaney William E IV Chief Scientific Officer | Grant | Mar 29, 2026 | 14.0K | $0.00 | $0 | Form 4 ↗ |
Okazaki Jason A CEO and President | Grant | Mar 29, 2026 | 50.8K | $0.00 | $0 | Form 4 ↗ |